Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin S Daniel

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
The Australasian Journal of Dermatology|December 17, 2025
Waiting for Access: How Bureaucracy Blocks Innovation in Australian DermatologyConor Larney, Peter Foley, Benjamin S Daniel
The Australasian Journal of Dermatology|August 3, 2019
Flare of palmoplantar psoriasis with ustekinumabBenjamin S Daniel, Chris Baker, Peter Foley
The Australasian Journal of Dermatology|November 1, 2025
Is the Future Oral? Towards Sustainable and Patient-Centered Biologic Treatment in DermatologyConor Larney, Peter Foley, Benjamin S Daniel
The Australasian Journal of Dermatology|March 24, 2025
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic ReviewConor Larney, Peter Foley, Benjamin S Daniel
Immunology and Allergy Clinics of North America|May 8, 2012
Rituximab and its use in autoimmune bullous disordersBenjamin S Daniel, Dédée F Murrell, Pascal Joly
Dermatologic Clinics|September 20, 2011
The autoimmune blistering diseases in Australia: status and servicesBenjamin S Daniel, Andrew Dermawan, Dédée F Murrell
Dermatologic Clinics|September 20, 2011
Rituximab and its use in autoimmune bullous disordersBenjamin S Daniel, Dédée F Murrell, Pascal Joly
The Australasian Journal of Dermatology|December 31, 2024
Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case SeriesConor Larney, Peter Foley, Kurt Gebauer, et al.
The Australasian Journal of Dermatology|May 6, 2020
Real world experience using Ciclosporin in psoriasis: Efficacy and toxicity in the Australasian Psoriasis RegistryWilliam Berry, Benjamin S Daniel, Christopher Baker, et al.
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The Australasian Journal of Dermatology|December 17, 2025
Waiting for Access: How Bureaucracy Blocks Innovation in Australian DermatologyConor Larney, Peter Foley, Benjamin S Daniel
The Australasian Journal of Dermatology|August 3, 2019
Flare of palmoplantar psoriasis with ustekinumabBenjamin S Daniel, Chris Baker, Peter Foley
The Australasian Journal of Dermatology|November 1, 2025
Is the Future Oral? Towards Sustainable and Patient-Centered Biologic Treatment in DermatologyConor Larney, Peter Foley, Benjamin S Daniel
The Australasian Journal of Dermatology|March 24, 2025
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic ReviewConor Larney, Peter Foley, Benjamin S Daniel
Immunology and Allergy Clinics of North America|May 8, 2012
Rituximab and its use in autoimmune bullous disordersBenjamin S Daniel, Dédée F Murrell, Pascal Joly
Dermatologic Clinics|September 20, 2011
The autoimmune blistering diseases in Australia: status and servicesBenjamin S Daniel, Andrew Dermawan, Dédée F Murrell
Dermatologic Clinics|September 20, 2011
Rituximab and its use in autoimmune bullous disordersBenjamin S Daniel, Dédée F Murrell, Pascal Joly
The Australasian Journal of Dermatology|December 31, 2024
Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case SeriesConor Larney, Peter Foley, Kurt Gebauer, et al.
The Australasian Journal of Dermatology|May 6, 2020
Real world experience using Ciclosporin in psoriasis: Efficacy and toxicity in the Australasian Psoriasis RegistryWilliam Berry, Benjamin S Daniel, Christopher Baker, et al.
The Australasian Journal of Dermatology|April 17, 2024
Dupilumab for chronic actinic dermatitis: A case series and review of the literatureZachary Holmes, Peter Foley, Chris Baker, et al.
Pageof 5